Sort

Search

01/01/2023 Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort
Rojo-López M.I., Bermúdez-López M., Castro E., Farràs C., Torres G., Pamplona R., Lecube A., Valdivielso J.M., Fernández E., Julve J., Castelblanco E., Franch-Nadal J., Alonso N., Granado-Casas M., Mauricio D., Miquel E., Ortega M., Barbé F., González J., Barril S., Sánchez-de-la-Torre M., Portero-Otín M., Jové M., Hernández M., Rius F., Godoy P., Alonso M.M.. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4.900(Q1/2D).
01/01/2023 Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study
Dieberger A.M., Obermayer-Pietsch B., Harreiter J., Desoye G., van Poppel M.N.M., Simmons D., Corcoy R., Perez J.M.A., Kautzky-Willer A., Damm P., Mathiesen E., Jensen D.M., Andersen L.L.T., Dunne F., Lapolla A., Dalfra M.G., Bertolotto A., Jelsma J.G.M., Galjaard S., Wender-Ozegowska E., Zawiejska A., Hill D., Devlieger R., Snoek F.J.. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9)DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4.200(Q1/3D).
01/01/2023 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.02.002. PMID:37268528. IF:1.800(Q3/8D).
01/01/2023 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?
Velilla T.A., Guijarro C., Ruiz R.C., Piñero M.R., Marcos J.F.V., Pérez A.P., López M.A.B., López A.M., Donaire J.A.G., Obaya J.C., Guerra L.C., Carratalá V.P., Cabello I.E., Lazo M.S., Rodrigo M.M.C., Prieto J.M.M., Doblas J.J.G., Soto A.B.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?. Neurology Perspectives. 2023; 3(2)DOI:10.1016/j.neurop.2023.100126. PMID:. IF:(Q/D).
01/01/2023 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2)DOI:10.1016/j.rccl.2022.11.004. PMID:. IF:(Q/D).
01/01/2023 Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital
Bellido V., Freckman G., Pérez A., Galindo R.J.. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11)DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3.700(Q2/4D).
01/01/2023 NAD+ Precursors: A Physiological Reboot?
Niño-Narvión J., Camacho M., Julve J.. NAD+ Precursors: A Physiological Reboot?. Nutrients. 2023; 15(20)DOI:10.3390/nu15204479. PMID:. IF:(Q/D).
01/01/2023 PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Jr, ARO, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. ADVANCES IN THERAPY. 2023; 40(2)DOI:10.1007/s12325-022-02360-6. PMID:36502449. IF:3.400(Q2/3D).